comparemela.com

Latest Breaking News On - Prnewswire willow biosciences inc - Page 1 : comparemela.com

WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION

WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Willow Biosciences Advances Its Work On THC; Plans To Launch In The [ ]

19 gennaio 2021 13:02 Fonte: Adnkronos #altro VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ Willow Biosciences Inc. ( Willow or the Company ) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has advanced its work on its proprietary yeast strain for production of Tetrahydrocannabinol ( THC ), and plans to commercially launch in the Canadian market. We are excited to announce our proprietary THC yeast biosynthesis production process for launch in the Canadian market, said Trevor Peters, Willow s President and Chief Executive Officer. Our platform technology enables us to produce a variety of cannabinoids and leverage our previous work on CBG. From conversations with prospective customers in Canada, we believe that there is significant demand for consistent, high-purity THC. The flavourless, odorless attributes of our finished product make it suitable as a core ingredient for the cannabis 2.0 market in Canada. There is also strong demand for a more sustainable and en

Willow Biosciences Advances Its Work On THC; Plans To Launch In The Canadian Market

Willow Biosciences Advances Its Work On THC; Plans To Launch In The Canadian Market 19 gennaio 2021 | 13.01 LETTURA: 5 minuti VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ Willow Biosciences Inc. ( Willow or the Company ) (TSX: WLLW) (OTCQX: CANSF) is pleased to announce that it has advanced its work on its proprietary yeast strain for production of Tetrahydrocannabinol ( THC ), and plans to commercially launch in the Canadian market. We are excited to announce our proprietary THC yeast biosynthesis production process for launch in the Canadian market, said Trevor Peters, Willow s President and Chief Executive Officer. Our platform technology enables us to produce a variety of cannabinoids and leverage our previous work on CBG. From conversations with prospective customers in Canada, we believe that there is significant demand for consistent, high-purity THC. The flavourless, odorless attributes of our finished product make it suitable as a

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.